Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 8Other 5Gynecologic 4Endocrine 3Tumor-Agnostic 1Plasma cell 1NET 1Myeloid 1Head & Neck 1Gastrointestinal 1

Conditions

Neuroendocrine Tumors 1Multiple Endocrine Neoplasia Type 1 1Growth Hormone-Secreting Pituitary Adenoma 1Feeding Behavior 1Cardiovascular Diseases 1

Interventions

lutetium Lu 177 dotatate 36Everolimus 32pembrolizumab 24Temozolomide 21Magnetic Resonance Spectroscopy 21Nivolumab 18lenvatinib 17gallium Ga 68 dotatate 16cabozantinib 15Cisplatin 15lanreotide 143-Iodobenzylguanidine 14Capecitabine 13trametinib 12dabrafenib 12Bevacizumab 12Octreotide 11Surveys and Questionnaires 10Surgical Procedures, Operative 10Sunitinib 10Radiosurgery 10Positron Emission Tomography Computed Tomography 10Blood Specimen Collection 10Sorafenib 9Paclitaxel 9Ipilimumab 9Carboplatin 9surufatinib 8Etoposide 8Doxorubicin 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Diet, Mediterranean × Endocrine × Clear all
NCT06949891 2025-04-29

KETOACRO

Erasmus Medical Center

Phase NA Recruiting
60 enrolled
Endocrine

Growth Hormone-Secreting Pituitary Adenoma

NCT03592940 2018-07-19

NetNutr

Federico II University

Completed
100 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT01852721 2013-09-06

Effects of the Mediterranean Diet on Cardiovascular Risk Profile in Men and Women (ALIMED)-Part 2

Laval University

Phase NA Completed
123 enrolled
Endocrine

Cardiovascular Diseases, Feeding Behavior, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡